ir.oncosec.com
OverviewCorrecting The Dots
http://ir.oncosec.com/
Correcting The Dots
http://ir.oncosec.com/
TODAY'S RATING
>1,000,000
Date Range
HIGHEST TRAFFIC ON
Wednesday
LOAD TIME
0.8 seconds
16x16
32x32
PAGES IN
THIS WEBSITE
16
SSL
EXTERNAL LINKS
79
SITE IP
34.235.255.140
LOAD TIME
0.812 sec
SCORE
6.2
Overview | ir.oncosec.com Reviews
https://ir.oncosec.com
Correcting The Dots
ir.oncosec.com
Analyst Coverage
https://ir.oncosec.com/analyst-coverage
Media & Events. Noble Life Science Partners.
Email Alerts
https://ir.oncosec.com/email-alerts
Media & Events. Please fill out the form below to receive company press releases via email when they occur. Annual & Quarterly Reports. We respect your privacy. We do not sell, rent, or loan any information to any third party. Any information you give us is held with the utmost care and security, and will be used only in ways to which you have consented.
Events
https://ir.oncosec.com/events
Media & Events. There are no upcoming events scheduled at this time. Sign up here. To receive notices about upcoming events and press releases. AACR Special Conference on Engineering and Physical Sciences in Oncology. June 27, 2016 • 5:00 pm ET. Westin Boson Waterfron, Boston, MA. June 16, 2016 • 4:15 pm CEST. Salzburg Congress, Salzburg, Austria. Third Quarter 2016 Financial Results Conference Call. June 9, 2016 • 4:15 pm ET. Apr 30, 2016. Sachs 2nd Annual Immuno-Oncology: BD&L and Investment Forum.
Presentations
https://ir.oncosec.com/presentations
Media & Events. Corporate Presentation - July 2016. Uploaded: Jul 5, 2016. OncoSec First Quarter 2016 Financial Results Conference Call December 2015. Uploaded: Dec 10, 2015. OncoSec Fourth Quarter and Fiscal Year End Conference Call October 2015. Uploaded: Oct 15, 2015. OncoSec Annual Shareholder Meeting Webcast - July 2015. Uploaded: Aug 3, 2015. Corporate Update Webinar with CEO Punit Dhillon - March 2015. Uploaded: Mar 24, 2015.
Governance Docs
https://ir.oncosec.com/governance-docs
Media & Events. Uploaded: Sep 4, 2015. Code of Business Conduct and Ethics. Uploaded: Sep 4, 2015. Uploaded: Jan 17, 2014. Uploaded: Dec 4, 2014. Nominations and Corporate Governance Committee Charter. Uploaded: Jan 17, 2014.
TOTAL PAGES IN THIS WEBSITE
16
Investor Relations « Omega Protein
News & Media. Science & Innovation. Annual Reports and Proxy Statements. Day High: 15.75. Day Low: 15.24. Prior Close: 15.33. Aug 7, 2015. Delayed 20 min., by eSignal. At Omega Protein, we strive to be a respected leader in every market we serve by providing customers with premium, sustainable products for a healthier world. In pursuit of this mission, we are committed to maximizing shareholder value through the introduction of new and innovative products. Aug 5, 2015. Jul 30, 2015. Day High: 15.75.
Omnicare : Investors
Omnicare, Inc., a Fortune 500 company based in Cincinnati, Ohio, provides comprehensive pharmaceutical services to patients and providers across the United States. As the market-leader in professional pharmacy, related consulting and data management services for skilled nursing, assisted living and other chronic care settings, Omnicare leverages its unparalleled clinical insight into the geriatric market along with some of the industry's most innovative technological capabilities to the benefit o...
Investor Relations | Omnicell, Inc.
Skip to main navigation. Omnicell, Inc., is a leading provider of solutions targeting patient safety and operational efficiency in healthcare facilities. From the point at which a medication arrives at the receiving dock to the time it is administered, Omnicell systems store it, package it, bar code it, order it, issue it, and charge it. Mar 27, 2018. Mercyhealth Adopts Omnicell's XR2 Automated Central Pharmacy System to Enhance Patient Safety. Mar 22, 2018. View all press releases. Mar 27, 2018. IvSTATI...
Oncobiologics - Investor Overview
Regulatory and Clinical Development. GMP Manufacturing Facility Tour. Oncobiologics is a clinical stage biopharmaceutical company focused on identifying, developing, manufacturing and commercializing complex biosimilar therapeutics. Our current focus is on technically challenging and commercially attractive monoclonal antibodies (mAbs), in the disease areas of immunology and oncology. Our strategy is to leverage our BioSymphony Platform to cost-effectively develop these biosimilars on an accelera...
OncoGenex Pharmaceuticals, Inc. - Investor Relations
Scientific Publications and Presentations. Scientific Publications and Events. Aug 4, 2016. OncoGenex Second Quarter 2016 Conference Call. Aug 16, 2016. Oct 13, 2016. OncoGenex ENSPIRIT Trial Conference Call. Exploring New Compounds to Meet the Challenge of Cancer Treatment Resistance. Phase 2 in bladder, lung, pancreatic and prostate cancers. Role of Hsp27 and Apatorsen (OGX-427). Aug 1, 2017. Achieve Life Sciences Announces Closing of Merger with OncoGenex Pharmaceuticals. Jun 13, 2017. May 15, 2017.
Overview
Media & Events. Advancing a lead portfolio of gene therapies for cancer. Platform focused on reversing tumor immune suppression. Phase II clinical programs focused on addressing unmet need of T-cell poor tumors. Clinical data demonstrates proof of concept of the technology. Rapid preclinical development platform. OncoSec Announces Strategic Relocation Of Office And Laboratories. Mar 20, 2018. Jan 31, 2018. Sign up for email alerts. Be the first to receive breaking news.
Overview - Oncothyreon
Annual Reports and Proxy. We are committed to serving the best interests of our shareholders. If you require assistance or have questions regarding the key shareholder information and financial reports available here please contact. 027 (- 7.56%). 4:00 PM ET on Aug 7, 2015. Delayed at least 20 minutes. Aug 6, 2015. Oncothyreon Reports Second Quarter 2015 Financial Results. Jul 30, 2015. Oncothyreon Announces Second Quarter 2015 Financial Results Conference Call. View all recent releases ».
IR Overview :: One Horizon Group, Inc. (OHGI)
Carrier Products and Services. One Horizon's Carrier Technology. Billing and Provisioning Platform. Rapid Deployment and Simple Integration. The Aishuo Mobile App. Enterprise Products and Services. One Horizon's Enterprise Technology. Rapid Deployment and Simple Integration. Limitations of Mobile VoIP. Horizon Library For Developers. One Horizon Group, Inc. (NASDAQ: OHGI). SeeThru Equity Research Report. Outstanding: 32,921,533. As of May 15, 2015). One Horizon Group, Inc. Tierney Building - T1017.
Investor Information - ONEOK - Investor Relations Home
Q2 ONEOK Inc. and ONEOK Partners Earnings Conference Call. 160;at 11:00 am ET. Q2 ONEOK Inc. and ONEOK Partners Earnings Conference Call. Wednesday, August 5, 2015 . 11:00 am ET . Click here for webcast. Click here to add this event to your calendar. ONEOK is a FORTUNE 500 company and is included in Standard and Poor's (S&P) 500 Stock Index. View 2014 Annual Report. ONEOK and ONEOK Partners to Participate in the Tuohy Brothers Annual Energy Conference. ONEOK Announces Second-quarter 2015 Results. Form 1...
Investor Information - ONEOK Partners - Investor Relations Home
Q2 2015 ONEOK Inc. and ONEOK Partners Earnings Conference Call. 160;at 11:00 am ET. Q2 2015 ONEOK Inc. and ONEOK Partners Earnings Conference Call. Wednesday, August 5, 2015 . 11:00 am ET . Click here for webcast. Click here to add this event to your calendar. Its general partner is a wholly owned subsidiary of ONEOK, Inc. A pure-play publicly traded general partner, which owns 36.8 percent of the overall partnership interest, as of June 30, 2015. More. View 2014 Annual Report. Form 8-K Report of unsche...
Банк Открытие, тел. 8-800-700-7877: кредитование, кредиты малому бизнесу, ипотека, депозиты. Банк для Москвы. Банк для России.
Интернет-банк «Открытие». Для частных лиц и бизнеса. Объединив банки, мы объединили и сайты банков. Войти в привычный вам интернет-банк можно здесь:. Система «Линк». Система «Линк». Для частных клиентов ФК «Открытие». Для корпоративных клиентов ФК «Открытие». Интернет- и мобильный банк). Для частных клиентов филиала «Петрокоммерц». Отчетность и публикации банка «Открытие». Отчетность и публикации банка «Открытие». Заимствования на рынке капитала. Банк «Открытие». Пресс-релиз за 1-е полугодие 2016 года.
